Similar articles for PMID: 19757563

Year	Number of Results
1955	1
1956	1
1958	1
1959	1
1979	1
1980	4
1981	4
1982	9
1983	7
1984	4
1985	3
1986	8
1987	5
1988	4
1990	2
1991	3
1992	2
1994	6
1995	7
1996	3
1997	5
1998	5
1999	4
2000	12
2001	8
2002	4
2003	4
2004	6
2005	17
2006	24
2007	25
2008	42
2009	95
2010	5
2011	7
2012	7
2013	2
2014	6
2015	3
2016	6
2017	6
2018	5
2019	5
2020	7
2021	9
2022	3
2024	0

1

Efficacy of two canine parvovirus vaccines for inducing seroconversion in Rottweiler and Doberman pinscher pups with various levels of maternally derived antibodies.

Coyne MJ. Coyne MJ. Vet Ther. 2000 Winter;1(1):35-42. Vet Ther. 2000. PMID: 19757563 Clinical Trial.

2

Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.

Larson LJ, Schultz RD. Larson LJ, et al. Am J Vet Res. 1997 Apr;58(4):360-3. Am J Vet Res. 1997. PMID: 9099379 Clinical Trial.

3

Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose.

Buonavoglia C, Cavalli A, Tempesta M, Voight V, Buonavoglia D, Corrente M, Sagazio P. Buonavoglia C, et al. New Microbiol. 1995 Oct;18(4):371-5. New Microbiol. 1995. PMID: 8590389

4

Serologic response of pups to the low-passage, modified-live canine parvovirus-2 component in a combination vaccine.

O'Brien SE. O'Brien SE. J Am Vet Med Assoc. 1994 Apr 15;204(8):1207-9. J Am Vet Med Assoc. 1994. PMID: 8014088

5

Immunogenicity of a low-passage, high-titer modified live canine parvovirus vaccine in pups with maternally derived antibodies.

Hoare CM, DeBouck P, Wiseman A. Hoare CM, et al. Vaccine. 1997 Feb;15(3):273-5. doi: 10.1016/s0264-410x(96)00184-3. Vaccine. 1997. PMID: 9139485

6

Antibody levels and protection to canine parvovirus type 2.

Elia G, Cavalli A, Cirone F, Lorusso E, Camero M, Buonavoglia D, Tempesta M. Elia G, et al. J Vet Med B Infect Dis Vet Public Health. 2005 Sep-Oct;52(7-8):320-2. doi: 10.1111/j.1439-0450.2005.00870.x. J Vet Med B Infect Dis Vet Public Health. 2005. PMID: 16316392 Clinical Trial.

7

Response of pups to modified-live canine parvovirus component in a combination vaccine.

O'Brien SE, Roth JA, Hill BL. O'Brien SE, et al. J Am Vet Med Assoc. 1986 Apr 1;188(7):699-701. J Am Vet Med Assoc. 1986. PMID: 3700224

8

Efficacy of vaccination at 4 and 6 weeks in the control of canine parvovirus.

De Cramer KG, Stylianides E, van Vuuren M. De Cramer KG, et al. Vet Microbiol. 2011 Apr 21;149(1-2):126-32. doi: 10.1016/j.vetmic.2010.11.004. Epub 2010 Nov 9. Vet Microbiol. 2011. PMID: 21111542

9

Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant?

Larson LJ, Schultz RD. Larson LJ, et al. Vet Ther. 2008 Summer;9(2):94-101. Vet Ther. 2008. PMID: 18597247 Clinical Trial.

10

Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.

Siedek EM, Schmidt H, Sture GH, Raue R. Siedek EM, et al. Berl Munch Tierarztl Wochenschr. 2011 Jan-Feb;124(1-2):58-64. Berl Munch Tierarztl Wochenschr. 2011. PMID: 21306055 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

365 results

Results by year